TFRC and neoplasm: Studies are currently underway to evaluate therapeutic uses of TfR-targeting, enhanced by iron chelation, of breast cancer and the macrophages in the tumor microenvironment, and their potential use to sensitize breast cancer to chemo- and immunotherapy.